2007 ESH‐ESC Guidelines for the management of arterial hypertension (Q56970799)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2007

Language	Label	Description	Also known as
English	2007 ESH‐ESC Guidelines for the management of arterial hypertension	scientific article published on 01 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

arterial hypertension

1 reference

based on heuristic

inferred from title

Anna Dominiczak

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Renata Cífková

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Krzysztof Narkiewicz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Luis Miguel Ruilope

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sverre E. Kjeldsen

9

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

European Society of Cardiology

18

object named as

European Society of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Roland E. Schmieder

14

object named as

Roland E Schmieder

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

7

object named as

Guido Grassi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Andrzej Rynkiewicz

13

object named as

Andrzej Rynkiewicz

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Giuseppe Mansia

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Guy De Backer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Robert Fagard

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Giuseppe Germano

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Anthony M Heagerty

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Stephane Laurent

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Harry A Struijker Boudier

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alberto Zanchetti

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

European Society of Hypertension

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 January 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

135-232

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mortality over a period of 10 years in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Global burden of hypertension: analysis of worldwide data

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Selected major risk factors and global and regional burden of disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Expert consensus document on arterial stiffness: methodological issues and clinical applications

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular mortality in hypertensive men according to presence of associated risk factors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The long-term prognostic value of the resting and postexercise ankle-brachial index

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic significance of left ventricular mass change during treatment of hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Heart rate and cardiovascular mortality: the Framingham Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure and heart rate variabilities in normotensive and hypertensive human beings.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure measuring devices: recommendations of the European Society of Hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory blood-pressure monitoring

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Circadian variation of blood-pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Early morning attenuation of endothelial function in healthy humans.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reproducibility of home blood pressure measurements over a 1-year period

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

How common is white coat hypertension?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Alerting reaction and rise in blood pressure during measurement by physician and nurse.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevalence, persistence, and clinical significance of masked hypertension in youth.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

American College of Sports Medicine position stand. Exercise and hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure reactions to acute psychological stress and future blood pressure status: a 10-year follow-up of men in the Whitehall II study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Impact of left ventricular hypertrophy on blood pressure responses to exercise

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Lack of independent relationships between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure stress reactivity and left ventricular mass in a random community sample of African-American and caucasian men and women.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of different antihypertensive drug classes on central aortic pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Use of arterial transfer functions for the derivation of aortic waveform characteristics.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Multiple biomarkers for the prediction of first major cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Molecular genetics of human hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Genetic factors in hypertension--what is known and what does it mean?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pharmacogenomics of hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Molecular mechanisms of human hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The role of carotid arterial intima-media thickness in predicting clinical coronary events

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Frequency domain measures of heart period variability and mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Recommendations for chamber quantification

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Validity of revised Doppler echocardiographic algorithms and composite clinical and angiographic data in diagnosis of diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Systolic and diastolic heart failure in the community.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Left atrium size and the risk of cardiovascular death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Atrial fibrillation in hypertension: predictors and outcome

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ultrasonic backscatter and collagen in normal ventricular myocardium.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Medical treatment of peripheral arterial disease and claudication

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The relationship between ankle-arm index and mortality in older men and women.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aortic stiffness is an independent predictor of fatal stroke in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Histology of subcutaneous small arteries from patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic significance of small-artery structure in hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of coronary vascular endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Circulating endothelial progenitor cells and cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Assessing kidney function--measured and estimated glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

On the importance of estimating renal function for cardiovascular risk assessment

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Retinal vascular tree morphology: a semi-automatic quantification.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cerebral white matter lesions and the risk of dementia.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Evidence-based medicine in hypertension: what type of evidence?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Systematic review: antihypertensive drug therapy in black patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Treatment of isolated systolic hypertension: the SHELL study results

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin receptor blockers and myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Never mind the quality, feel the width--ALLHAT revisited

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertensive myocardial fibrosis.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Losartan and prevention of atrial fibrillation recurrence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Carotid Intima-Media Thickness and Antihypertensive Treatment

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind t

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Assessment of carotid plaque composition in hypertensive patients by ultrasonic tissue characterization: a validation study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term effects of intensive blood-pressure lowering on arterial wallstiffness in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effects of antihypertensive treatment on cognitive function: results from the HOPE study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The epidemiology of impaired glucose tolerance and hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

New-onset diabetes and antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Old antihypertensives and new diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ramipril and the development of diabetes.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of ramipril on the incidence of diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Diabetes and cardiovascular events in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Feasibility of treating prehypertension with an angiotensin-receptor blocker

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Predictors of adverse outcome among patients with hypertension and coronary artery disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mechanisms responsible for sympathetic activation by cigarette smoking in humans.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Predictors of 7-year changes in exercise blood pressure: effects of smoking, physical fitness and pulmonary function

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Association between smoking and blood pressure: evidence from the health survey for England

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

How smoking affects blood pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mortality in relation to smoking: 40 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The risk of myocardial infarction after quitting smoking in men under 55 years of age.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Lifetime cumulative exposure to secondhand smoke and risk of myocardial infarction in never smokers: results from the Western New York health study, 1995-2001.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Moderate alcohol use and reduced mortality risk: Systematic error in prospective studies

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Alcohol, hypertension and the cardiovascular system: a critical appraisal

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Patterns of alcohol intake and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

How Far Should Salt Intake Be Reduced?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Dietary salt and hypertension: a scientific issue or a matter of faith?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Does fish oil lower blood pressure? A meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure responses in healthy older people to 50 g carbohydrate drinks with differing glycaemic effects

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Correlates of the hemodynamic determinants of blood pressure.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Body weight, weight change, and risk for hypertension in women

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renin/prorenin receptors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin receptor blockers: therapeutic targets and cardiovascular protection

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Compliance with antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Results of the pilot study for the Hypertension in the Very Elderly Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The role of diastolic blood pressure when treating isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Silent cerebral white matter lesions in middle-aged essential hypertensive patients.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Preventable stroke and stroke prevention

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Coronary risk prediction in adults (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Fluctuations of radial artery distensibility throughout the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Investigation of relation between use of oral contraceptives and thromboembolic disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cerebrovascular diseases associated with the use of oral contraceptives. A review of the English-language literature

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Combined oral contraceptive use among women with hypertension: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Progestogen-only pills and high blood pressure: is there an association? A literature review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Conventional and ambulatory blood pressure and menopause in a prospective population study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight--the Chin-Shan Community Cardiovascular Cohort study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Task Force II: blood pressure measurement and cardiovascular outcome.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory blood pressure in pregnancy and fetal growth.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Recording diastolic blood pressure in pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood-pressure measurement and classification in pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Nutrient-restricted fetus and the cardio-renal connection in hypertensive offspring.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Fortnightly review: management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Treatment of hypertensive complications in pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cardiovascular risk factors in healthy women with previous gestational hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Influence of metabolic syndrome on hypertension-related target organ damage

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic syndrome and target organ damage in untreated essential hypertensives.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

C-reactive protein: a critical update

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Ph

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Use of beta-blockers in obesity hypertension: potential role of weight gain

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effects of thiazolidinediones on blood pressure levels - a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Sleep apnoea and hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Obstructive sleep apnea and hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Update on Hypertension Management: obstructive sleep apnea and hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Statins and the primary prevention of cardiovascular events

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Status of lipids as a risk factor for stroke

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A strategy to reduce cardiovascular disease by more than 80%

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Acanthocyturia--a characteristic marker for glomerular bleeding

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renal-artery stenosis

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Pheochromocytoma: presentation, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Diagnosis and localization of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The genetic basis of pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The current epidemic of primary aldosteronism: causes and consequences

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Primary aldosteronism: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Cushing's Syndrome: important issues in diagnosis and management

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Sleep-related breathing disorder is an independent risk factor for systemic hypertension.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Daily usage and efficiency of remote home monitoring in hypertensive patients over a one-year period.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Worldwide prevalence of hypertension: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Why is hypertension so frequently uncontrolled in secondary prevention?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study.

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Practice Guidelines For Primary Care Physicians

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Lack of placebo effect on ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Prognostic value of 24-hour blood pressure variability

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Difference Between Clinic and Daytime Blood Pressure Is Not a Measure of the White Coat Effect

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood Pressure Response During Treadmill Testing as a Risk Factor for New-Onset Hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Renoprotective effects of renin-angiotensin-system inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Persistent blood pressure increase induced by heavy smoking

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The smoothness index

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Secondary Hypertension: Sleep Apnea

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Circadian Variation in Circulating Platelet Aggregates

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1080%2F08037050701461084

21 January 2018

Identifiers

10.1080/08037050701461084

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17846925%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56970799&oldid=2084980607"